Abstract
Multiple sclerosis (MS) pathology is marked by the massive infiltration of myelin-specific T cells into the central nervous system (CNS). During active disease, pro-inflammatory Th1/Th17 cells predominate over immunoregulatory Th2/Treg cells. Here, we show that calpain inhibition downregulates Th1/Th17 inflammatory cytokines and mRNA in MS patient peripheral blood mononuclear cells (PBMCs) activated with anti-CD3/28 or MBP. Interestingly, calpain inhibition elevated IDO gene expression in MS PBMCs, which was markedly decreased in calpain expressing cells. Functional assay showed that incubation of MS patient PBMCs with calpain inhibitor or recombinant IDO attenuates T cell proliferation. These results suggest that calpain inhibition may attenuate MS pathology and augment the efficacy of standard immunomodulatory agents used to treat this disease.
Original language | English |
---|---|
Pages (from-to) | 179-185 |
Number of pages | 7 |
Journal | Journal of Neuroimmunology |
Volume | 232 |
Issue number | 1-2 |
DOIs | |
State | Published - Mar 2011 |
Externally published | Yes |
Keywords
- Calpain
- Indoleamine 2, 3-dioxygenase
- Multiple sclerosis
- Peripheral blood mononuclear cells
- Th17